peripheral artery disease

Review

Intravascular Imaging for Infra-Inguinal Peripheral Artery Disease Intervention

07/12/2023

Daniel J. Snyder , MD;

Robert S. Zilinyi , MD;

Sonal Pruthi , MD;

Sareena George , MD;

Ari J. Mintz , DO;

Sanjum S. Sethi , MD, MPH;

Sahil A. Parikh , MD, FACC, FSCAI;

The authors review the applications and supporting data for the use of intravascular ultrasound and optical coherence tomography in infrainguinal endovascular intervention.

The authors review the...

07/12/2023

Vascular Disease Management

Original Contribution

Short-Term Outcomes After Retrograde Versus Antegrade Crossing Approaches for Femoropopliteal Occlusive Disease

11/30/2022

Steven Meadors , MD;

Andrea Klein , MD;

Omar Jawaid , MD;

Rahul Banerjee ;

Mohamed Amer Alaiti , MD;

Gregory Modrall , MD;

Ehrin J. Armstrong , MD, MSc, FACC;

Subhash Banerjee , MD, FSCAI;

Haekyung Jeon-Slaughter , PhD;

Bala Ramanan , MD, MBBS;

Shirling Tsai , MD;

Few studies have directly compared procedural details and outcomes after retrograde vs antegrade crossing of FP lesions.

Few studies have directly...

11/30/2022

Journal of Invasive Cardiology

Brief Contribution

Adverse Events With Intravascular Lithotripsy After Peripheral and Off-Label Coronary Use: A Report From the FDA MAUDE Database

12/01/2021

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Subhash Banerjee , MD, FSCAI;

Yashasvi Chugh , MD;

Santiago Garcia , MD;

M. Nicholas Burke , MD;

Jaikirshan J. Khatri , MD;

Mehdi H. Shishehbor , DO, MPH, PhD;

Kevin J. Croce , MD, PhD;

Khaldoon Alaswad , MD;

Bilal Murad , MD;

Currently only the peripheral intravascular lithotripsy device is approved for use in the United States. We queried the United States FDA MAUDE database from January 1, 2016 to December 14, 2020 for all reports of adverse events and modes of...

Currently only the peripheral...

12/01/2021

Journal of Invasive Cardiology

Blog

Study Shows Increased Risk For Foot Infection-Related Hospitalizations In People With Diabetes

08/19/2021

Adam L. Isaac , DPM, FACFAS;

According to a recent publication in Diabetologia, there is an increased risk of infection-related hospitalization in patients with diabetes.

According to a recent...

08/19/2021

Podiatry Today

Original Contribution

Chronic Total Occlusions: Association Between Characteristics and Mid-Term Outcomes in Critical Limb Ischemia

06/25/2021

Tobias Koch , MD;

Michael R. Jaff , MD, DO;

Jens Wiebe , MD;

Tobias Koppara , MD;

Erion Xhepa , MD, PhD;

George L. Adams , MD, MHS, MBA, FACC, FSCAI;

Thorsten Kessler , MD;

Jihad A. Mustapha , MD, FACC, FSCAI;

Tareq Ibrahim , MD;

Sara Finton , BSN;

Theresa McGoff , BSN;

Fadi Saab , MD, FACC, FSCAI;

Despite medical advancements, PAD and CLI continue to increase globally. Treatment for PAD/CLI varies widely and patients with CTOs may be more challenging to treat, requiring specialized crossing techniques and modalities. The objective of...

Despite medical advancements,...

06/25/2021

CardioVascular

Review

Peripheral Artery Disease, the Factor Xa Inhibitor Rivaroxaban, and the Role of the Podiatrist

06/08/2021

Ilaria Baralis , MD;

John O'Connor ;

John P. Benner , DO, NREMT-P;

John N. Evans , DPM, FACFAS, DABFAS;

This review serves to introduce the most recent data with a factor Xa inhibitor as a novel antithrombotic strategy for PAD.

This review serves to introduce...

06/08/2021

Clinical Update

The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI

05/21/2020

Robert E. Beasley , MD, FSCAI, FSIR;

Adam Zybulewski , MD;

Brandon P. Olivieri , MD, RPVI;

Michael Patel , MD;

Omosalewa Adenikinju , MD;

To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.

To understand the intent behind...

05/21/2020

Vascular Disease Management

Original Research

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation

05/15/2020

Riccardo Iorio , MD;

Attilio Cotroneo , MD;

Giuseppe Celano , MD;

Sante Bongo , MD;

Gaetano Chiricolo , MD;

Alberto Francesco Cereda , MD;

Giueseppe Massimo Sangiorgi , MD, PhD;

Paolo Cioffi , MD;

The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

The authors repot on 2 cases at...

05/15/2020

Vascular Disease Management

EP Tips & Techniques

Drug-Coated vs Uncoated Percutaneous Transluminal Angioplasty in Infrapopliteal Arteries: Six-Month Results of the Lutonix BTK Trial

07/23/2019

Jim Brooks ;

Jim Camden ;

Jihad A. Mustapha , MD, FACC, FSCAI;

Marianne Brodmann , MD;

Fadi Saab , MD, FACC, FSCAI;

Michael R. Jaff , MD, DO;

We hypothesized that a drug-coated balloon could improve treatment efficacy while maintaining safety when compared with percutaneous transluminal angioplasty for the treatment of atherosclerotic infrapopliteal arterial lesions.

We hypothesized that a...

07/23/2019

Journal of Invasive Cardiology

Original Contribution

Comparative Effectiveness Study of Drug-Eluting and Bare-Metal Peripheral Artery Stents in Endovascular Femoropopliteal Artery Revascularization

09/30/2018

Osvaldo S. Gigliotti , MD;

Haekyung Jeon-Slaughter , PhD;

Shirling Tsai , MD;

Omar Jawaid , MD;

Ehrin J. Armstrong , MD, MSc, FACC;

Hua Lu , MD;

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Tayo Addo , MD;

Houman Khalili , MD;

Subhash Banerjee , MD, FSCAI;

Mazen S. Abu-Fadel , MD;

This study compared clinically driven target-lesion revascularization, target-vessel revascularization, and target-limb revascularization outcomes at 1 year between drug-eluting stent and bare-metal stent treatments in a real-world setting.

This study compared clinically...

09/30/2018

Journal of Invasive Cardiology